RIGEL PHARMACEUTICALS INC

By person

22 insiders · 50 transactions

12.1×

Raul R. Rodriguez holds 12.1 times base salary in stock. $9.57M of shares against $787.41K in salary for 2025.

Salary from the company's own proxy. The shares are what Raul R. Rodriguez last reported holding, valued at $35.00, the price Common Stock was last bought or sold at on the open market here, on 22 Jun 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

RODRIGUEZ RAUL R

CEO, President

$988.40K (2)

$295.75K (5)

+$692.65K

273,362

1.46%

$9.57M

—

Duliege Anne-Marie

EVP & Chief Medical Officer

—

$653.30K (7) scheduled

−$653.30K

0.0000%

$0.00

−100.0%

Mayer Eldon C. III

EVP & Chief Commercial Officer

$607.87K (3)

—

+$607.87K

215,000

1.15%

$7.53M

+1,333%

Maynard Ryan D

EVP & CFO

—

$390.00K (1) scheduled

−$390.00K

0.0000%

$0.00

—

Ali-Jackson Kamil

Director

—

$160.43K (2) scheduled

−$160.43K

10,125

0.0542%

$354.38K

—

MOOS WALTER H

Director

—

$145.44K (1) scheduled

−$145.44K

18,472

0.0989%

$646.52K

—

Santos David A

EVP, Chief Commercial Officer

—

$109.28K (5)

−$109.28K

61,622

0.3299%

$2.16M

—

Furey Raymond J.

EVP, GC, CCO & Corp Sec

—

$59.65K (2)

−$59.65K

50,559

0.2707%

$1.77M

—

Cabatuan Nelson

VP,Finance & Princ.Acctg. Off.

—

$31.20K (1)

−$31.20K

0.0003%

$2.03K

−99.4%

Dummer Wolfgang

EVP & CMO

—

$8.95K (1)

−$8.95K

72,459

0.3879%

$2.54M

+160.2%

Schorno Dean L

EVP & Chief Financial Officer

$106.54K (2)

$103.90K (5)

+$2.65K

82,962

0.4441%

$2.90M

—

Kotzin Brian L.

Director

—

100,000

0.5353%

$3.50M

—

LYONS GARY A

Director

—

75,000

0.4015%

$2.63M

—

VANCE DOLLY

EVP Corp. Affairs, G.C., Sect.

—

60,260

0.3226%

$2.11M

+487.3%

HANNAH ALISON L.

EVP, Chief Medical Officer

—

35,025

0.1875%

$1.23M

—

Goodwin Bradford S

Director

—

35,000

0.1874%

$1.23M

+250.0%

Rojkjaer Lisa

EVP, Chief Medical Officer

—

34,003

0.1820%

$1.19M

—

Katkin Keith

Director

—

25,000

0.1338%

$875.00K

—

Wasman Jane

Director

—

18,250

0.0977%

$638.75K

—

LAPOINTE ANTHONY GREGG

Director

—

18,250

0.0977%

$638.75K

—

Frohlich Mark W

Director

—

7,000

0.0375%

$245.00K

—

MILLER MICHAEL PATRICK

Director

—

5,937

0.0318%

$207.80K

+3,075%

Individual transactions

Insider

Date

Role

Action

Price

Amount

MOOS WALTER H

20 Feb 2026

Director

Sold after exercise

4,000

$36.36

$145.44K

Duliege Anne-Marie

17 Sep 2018

EVP & Chief Medical Officer

Sold after exercise

37,500

$3.50

$131.25K

Duliege Anne-Marie

17 Sep 2018

EVP & Chief Medical Officer

Sold after exercise

115,500

$3.50

$404.25K

Duliege Anne-Marie

4 Sep 2018

EVP & Chief Medical Officer

Sold after exercise

16,500

$3.51

$57.86K

Maynard Ryan D

3 Nov 2017

EVP & CFO

Sold after exercise

100,000

$3.90

$390.00K

Show all 50 transactions →

RIGEL PHARMACEUTICALS INC

By person

Individual transactions

What was left out